Notable Announces $40M Series B Round to Fuel Development of Its Drug Discovery Platform for Personalized Oncology

NEXT STORY
Aptose Doses First CLL Patient in Phase 1 Study of CG-806 and Doses Third Cohort in Phase 1 Study of APTO-253
PREV STORY
Immunoassay Market Worth $21.2 Billion by 2025- Exclusive Report by Meticulous Research®
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Matrix Medical Network announces the appointment of Ian Worden as Vice President, Product & Marketing

SCOTTSDALE, Ariz., July 17, 2018 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix), a leading population ...

author_avatar
NASDAQ Market News

Aeglea BioTherapeutics Announces Oral Presentation of Preclinical Data on New Pipeline Therapeutic for Cystinuria at 2018 American Society of Nephrology

AUSTIN, Texas, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage ...

author_avatar
NASDAQ Market News

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis, Trends, and Forecasts, 2019-2025 – Market to Witness Healthy Growth, Driven by Low-cost Advantages

author_avatar
NASDAQ Market News